ATOSSA THERAPEUTICS, INC. Cost of Services (Deprecated 2018-01-31)
ATOSSA THERAPEUTICS, INC. (ATOS) reported Cost of Services (Deprecated 2018-01-31) of $1.21 million for the 3-month period ending 2015-03-31, per its 10-Q filed 2015-05-13.
Discontinued › Expense Statement › Cost of Sales
us-gaap:CostOfServices · last filed 2015-05-13
- ATOSSA THERAPEUTICS, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2015-03-31 was $1.21M.
- ATOSSA THERAPEUTICS, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2014-12-31 was $340.66K, a 1040.43% increase year-over-year.
- ATOSSA THERAPEUTICS, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2014-09-30 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. cost of services (deprecated 2018-01-31) for the quarter ending 2014-06-30 was $0.00, a 100.00% decline year-over-year.
- ATOSSA THERAPEUTICS, INC. cost of services (deprecated 2018-01-31) for fiscal 2014 was $340.66K, a 222.09% increase from fiscal 2013.
- ATOSSA THERAPEUTICS, INC. cost of services (deprecated 2018-01-31) for fiscal 2013 was $105.76K, a 195.88% increase from fiscal 2012.
- ATOSSA THERAPEUTICS, INC. cost of services (deprecated 2018-01-31) for fiscal 2012 was $35.74K.
- ATOSSA THERAPEUTICS, INC. cost of services (deprecated 2018-01-31) for fiscal 2011 was $0.00.
| Period end | Cost of Services (Deprecated 2018-01-31) 3 month | Cost of Services (Deprecated 2018-01-31) 6 month | Cost of Services (Deprecated 2018-01-31) 9 month | Cost of Services (Deprecated 2018-01-31) 12 month | Cost of Services (Deprecated 2018-01-31) 41 month | Cost of Services (Deprecated 2018-01-31) 44 month | Cost of Services (Deprecated 2018-01-31) 47 month | Cost of Services (Deprecated 2018-01-31) 50 month | Cost of Services (Deprecated 2018-01-31) 53 month | Cost of Services (Deprecated 2018-01-31) 56 month | Cost of Services (Deprecated 2018-01-31) 59 month |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2015-03-31 | $1.21M 10-Q · filed 2015-05-13 | $1.55M derived: sum of 2 quarters · filed 2015-05-13 | $1.55M derived: sum of 3 quarters · filed 2015-05-13 | $1.55M derived: sum of 4 quarters · filed 2015-05-13 | |||||||
| 2014-12-31 | $340.66K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $340.66K derived: sum of 2 quarters · filed 2015-03-30 | $340.66K derived: sum of 3 quarters · filed 2015-03-30 | $340.66K 10-K · filed 2015-03-30 | |||||||
| 2014-09-30 | $0.00 10-Q · filed 2014-11-12 | $0.00 derived: sum of 2 quarters · filed 2014-11-12 | $0.00 10-Q · filed 2014-11-12 | $29.87K derived: sum of 4 quarters · filed 2015-05-13 | |||||||
| 2014-06-30 | $0.00 10-Q · filed 2014-08-12 | $0.00 10-Q · filed 2014-08-12 | $29.87K derived: sum of 3 quarters · filed 2015-05-13 | $55.81K derived: sum of 4 quarters · filed 2015-05-13 | |||||||
| 2014-03-31 | $0.00 10-Q · filed 2015-05-13 | $29.87K derived: sum of 2 quarters · filed 2015-05-13 | $55.81K derived: sum of 3 quarters · filed 2015-05-13 | $58.16K derived: sum of 4 quarters · filed 2015-05-13 | $141.51K 10-Q · filed 2014-05-14 | ||||||
| 2013-12-31 | $29.87K derived: 10-K 12 month − 10-Q 9 month · filed 2015-03-30 | $55.81K derived: sum of 2 quarters · filed 2015-03-30 | $58.16K derived: sum of 3 quarters · filed 2015-03-30 | $105.76K 10-K · filed 2015-03-30 | $141.51K 10-K · filed 2014-03-27 | ||||||
| 2013-09-30 | $25.94K 10-Q · filed 2014-11-12 | $28.29K derived: sum of 2 quarters · filed 2014-11-12 | $75.89K 10-Q · filed 2014-11-12 | $81.65K derived: sum of 4 quarters · filed 2014-11-12 | $111.64K 10-Q · filed 2013-11-12 | ||||||
| 2013-06-30 | $2.36K 10-Q · filed 2014-08-12 | $49.95K 10-Q · filed 2014-08-12 | $55.72K derived: sum of 3 quarters · filed 2014-08-12 | $64.72K derived: sum of 4 quarters · filed 2014-08-12 | $85.70K 10-Q · filed 2013-08-14 | ||||||
| 2013-03-31 | $47.60K 10-Q · filed 2014-05-14 | $53.36K derived: sum of 2 quarters · filed 2014-05-14 | $62.36K derived: sum of 3 quarters · filed 2014-05-14 | $80.15K derived: sum of 4 quarters · filed 2014-05-14 | $83.34K 10-Q · filed 2013-05-15 | ||||||
| 2012-12-31 | $5.76K derived: 10-K 12 month − 10-Q 9 month · filed 2014-03-27 | $14.76K derived: sum of 2 quarters · filed 2014-03-27 | $32.55K derived: sum of 3 quarters · filed 2014-03-27 | $35.74K 10-K · filed 2014-03-27 | $35.74K 10-K · filed 2013-03-28 | ||||||
| 2012-09-30 | $9.00K 10-Q · filed 2013-11-12 | $26.79K derived: sum of 2 quarters · filed 2013-11-12 | $29.98K 10-Q · filed 2013-11-12 | $29.98K derived: sum of 4 quarters · filed 2013-11-12 | $29.98K 10-Q/A · filed 2013-01-22 | ||||||
| 2012-06-30 | $17.79K 10-Q · filed 2013-08-14 | $20.98K 10-Q · filed 2013-08-14 | $20.98K derived: sum of 3 quarters · filed 2013-08-14 | $20.98K derived: sum of 4 quarters · filed 2013-08-14 | |||||||
| 2012-03-31 | $3.20K 10-Q · filed 2013-05-15 | $3.20K derived: sum of 2 quarters · filed 2013-05-15 | $3.20K derived: sum of 3 quarters · filed 2013-05-15 | ||||||||
| 2011-12-31 | $0.00 derived: 10-K 12 month − 10-Q/A 9 month · filed 2013-03-28 | $0.00 derived: sum of 2 quarters · filed 2013-03-28 | $0.00 10-K · filed 2013-03-28 | ||||||||
| 2011-09-30 | $0.00 10-Q/A · filed 2013-01-22 | $0.00 10-Q/A · filed 2013-01-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cocrystal Pharma, Inc. (COCP) | United States | $0.022B | |
| Neuphoria Therapeutics Inc. (NEUP) | United States | $0.020B | -1.77 |
| Marker Therapeutics, Inc. (MRKR) | United States | $0.020B | -2.86 |
| Cellectar Biosciences, Inc. (CLRB) | United States | $0.020B | -1.03 |
| Shuttle Pharmaceuticals Holdings, Inc. (SHPH) | United States | $0.019B | -0.31 |
| ARTELO BIOSCIENCES, INC. (ARTL) | United States | $0.023B | |
| Rocket One Inc. (RKTO) | United States | $0.019B | |
| TherapeuticsMD, Inc. (TXMD) | United States | $0.024B | -117.87 |
| NextCure, Inc. (NXTC) | United States | $0.024B | -0.15 |
| Biofrontera Inc. (BFRI) | United States | $0.018B | -2.13 |